NetWalkRank:通过随机步行方法在多重基因调控网络中的癌症驱动基因优先级
IEEE transactions on computational biology and bioinformatics
|August 14, 2025
概括
鉴定癌症驱动基因 (CDG) 对瘤学至关重要. NetWalkRank在多重基因调控网络 (GRNs) 中优先考虑CDG,使用网络传播,在预测肝细胞癌驱动基因方面表现出显著的有效性.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 系统生物学 系统生物学
背景情况:
- 识别癌症驱动基因 (CDG) 对于了解癌症发展至关重要.
- 现有的方法往往难以整合复杂的,多阶段的基因信息.
- 多重基因调节网络 (GRNs) 提供了一个有前途的方法来模拟基因相互作用.
研究的目的:
- 开发一个新的基于网络的框架,NetWalkRank,用于优先考虑CDG.
- 为了利用多重的GRN和基因表达数据来增强CDG识别.
- 为了验证NetWalkRank在优先考虑肝细胞癌 (HCC) 驱动基因方面的有效性.
主要方法:
- 构建多重基因调控网络 (GRNs),整合多个阶段的基因信息.
- 在多重GRN中应用网络传播,以评估基因异常的传播.
- 利用基因表达分析数据作为网络分析的输入.
- 训练一个随机森林模型,使用NetWalkRank得分进行CDG预测.
主要成果:
- NetWalkRank有效地对肝细胞癌 (HCC) 的已知CDG进行了优先排序.
- 与现有的驱动基因排名方法相比,该框架表现出优越的性能.
- 在NetWalkRank得分上训练的随机森林模型实现了准确的CDG预测.
- 数字实验证实了拟议方法的效率和有效性.
结论:
- NetWalkRank提供了一个强大的框架来优先考虑癌症驱动基因.
- 整合跨多重GRN的信息显著提高了CDG的识别和预测.
- 该方法有望促进癌症研究和治疗策略的发展.
更多相关视频
10:13A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
11.3K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
